Pine River Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,600
Closed -$892K 611
2014
Q4
$892K Sell
5,600
-11,600
-67% -$1.81M 0.01% 544
2014
Q3
$2.42M Buy
17,200
+7,200
+72% +$940K 0.03% 407
2014
Q2
$1.19M Sell
10,000
-63,500
-86% -$7.35M 0.02% 503
2014
Q1
$9.06M Sell
73,500
-13,700
-16% -$1.66M 0.14% 180
2013
Q4
$9.95M Sell
87,200
-57,200
-40% -$6.51M 0.12% 199
2013
Q3
$16.2M Buy
144,400
+72,500
+101% +$7.86M 0.17% 122
2013
Q2
$7.09M Buy
+71,900
New +$7.46M 0.1% 187

Other funds holding AMGN

Pine River Capital Management's AMGN Position: Q4 2014 in Review

Pine River Capital Management sold out of Amgen (AMGN) in Q4 2014, closing a stake of 12,644 shares — an estimated $1.97M sold.

Pine River Capital Management first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $5.51M in Q2 2014. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Pine River Capital Management reported no remaining Amgen position as of Q4 2014 after selling out during the quarter.
  • Pine River Capital Management sold 12,644 Amgen shares in Q4 2014, an estimated $1.97M.
  • Pine River Capital Management first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
  • Pine River Capital Management's Amgen position peaked at $5.51M in Q2 2014.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Pine River Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.